Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The University of Oxford launched its first Public Engagement with Research Strategic Plan to an audience of over 100 staff at a reception at the Pitt Rivers Museum on 12th December 2016.

Cover of the Public Engagement with Research Strategic PlanOxford’s vision is to embed high-quality and innovative public engagement as an integral part of its research culture and practice, enhancing its position as a world-leading research institution.

The consultation process for the development of the Plan gathered views and input from across the University, involving academic and academic support staff at all levels and the Plan has been approved by the University’s Research Committee.

The purpose of the University’s Public Engagement with Research Strategic Plan is two-fold:

  • to frame an ambitious vision for Public Engagement with Research at Oxford;
  • to  identify the key steps towards it that will be undertaken in the next three years and against which to measure progress.

Find out more from the Public Engagement with Research Portal

Download the Strategic plan

Similar stories

Oxford vaccine reaches one billion doses released

The University of Oxford’s and our partners AstraZeneca have today announced that one billion doses of the ChAdOx1 nCov-19 coronavirus vaccine have been released, to more than 170 countries, marking a key milestone as part of the University and AstraZeneca’s joint vision to make the available to the world, on a not-for-profit basis for the world during the pandemic, and in perpetuity for low- and middle-income countries.

Research programme tackling COVID-19 variants of concern receives funding boost

A gift from the Red Avenue Foundation will enable the expansion of a major research programme aimed at rapidly identifying and interrogating emerging COVID-19 variants.

Phase I trial begins of new vaccine against the Plague

Researchers at the University of Oxford today launched a Phase 1 trial to test a new vaccine against plague.

New therapeutic targets identified in the treatment of psoriatic arthritis

Researchers identify two inflammatory-driving proteins, osteopontin and CCL2, highly expressed in psoriatic arthritis joints.

Treatment choice for rotator cuff disorders could create efficiency and savings for the NHS

A trial that evaluated the clinical and cost effectiveness of physiotherapy treatments for rotator cuff disorders suggests cost savings can be made while maintaining positive patient outcomes.